Femasys Inc
Research Femasys Inc (FEMY) on Bullrun: market cap USD 172.11M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFEMY
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 172.11M
- Financial periodQ1 2026
- RevenueUSD 424.89K
- Net income-USD 11.88M
- Free cash flow-USD 18.68M
- Gross margin344.4%
Valuation Snapshot
latest market cap is USD 172.11M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.29M | -USD 18.63M | -USD 19.22M | 62.0% | -0.47 | USD 9.27M | USD 4.70M | USD 5.87M |
| FY2024 | USD 1.63M | -USD 18.82M | -USD 20.21M | 66.6% | -0.85 | USD 3.45M | USD 7.44M | USD 2.30M |
| FY2023 | USD 1.07M | -USD 14.25M | -USD 11.42M | 64.5% | -0.93 | USD 21.72M | USD 6.70M | USD 18.35M |
| FY2022 | USD 1.21M | -USD 11.39M | -USD 11.14M | 63.4% | -0.96 | USD 12.96M | USD 1.02M | USD 15.24M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 172.11M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 34.57M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 25.69M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 21.22M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 10.63M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 46.04M | n/a | n/a | n/a |
About Femasys Inc
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Femasys Inc's market cap?
Femasys Inc's market capitalization is USD 172.11M.
What does Femasys Inc do?
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation.